| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.05 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.039 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |